Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carlo Lombardi and Gianenrico Senna.
Carlo Lombardi
Connection Strength
0.409
Gianenrico Senna
  1. Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life. Pulm Pharmacol Ther. 2019 02; 54:87-89.
    View in: PubMed
    Score: 0.200
  2. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
    View in: PubMed
    Score: 0.056
  3. Asthmatic patients in COVID-19 outbreak: Few cases despite many cases. J Allergy Clin Immunol. 2020 09; 146(3):541-542.
    View in: PubMed
    Score: 0.056
  4. The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study. Int Arch Allergy Immunol. 2019; 178(4):333-337.
    View in: PubMed
    Score: 0.050
  5. The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study. Clin Mol Allergy. 2018; 16:4.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.